BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 22170417)

  • 1. Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis.
    Reiberger T; Ferlitsch A; Payer BA; Pinter M; Homoncik M; Peck-Radosavljevic M;
    J Gastroenterol; 2012 May; 47(5):561-8. PubMed ID: 22170417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol.
    Reiberger T; Ulbrich G; Ferlitsch A; Payer BA; Schwabl P; Pinter M; Heinisch BB; Trauner M; Kramer L; Peck-Radosavljevic M;
    Gut; 2013 Nov; 62(11):1634-41. PubMed ID: 23250049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of HVPG-response to non-selective beta-blockers in patients with NASH cirrhosis and varices.
    Paternostro R; Becker J; Hofer BS; Panagl V; Schiffke H; Simbrunner B; Semmler G; Schwabl P; Scheiner B; Bucsics T; Bauer D; Binter T; Trauner M; Mandorfer M; Reiberger T
    Dig Liver Dis; 2022 Apr; 54(4):500-508. PubMed ID: 34799282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis.
    Kim SG; Kim TY; Sohn JH; Um SH; Seo YS; Baik SK; Kim MY; Jang JY; Jeong SW; Lee B; Kim YS; Suk KT; Kim DJ
    Am J Gastroenterol; 2016 Nov; 111(11):1582-1590. PubMed ID: 27575713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic prevention of variceal bleeding and rebleeding.
    Baiges A; Hernández-Gea V; Bosch J
    Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive response prediction in prophylactic carvedilol therapy for cirrhotic patients with esophageal varices.
    Kim HY; So YH; Kim W; Ahn DW; Jung YJ; Woo H; Kim D; Kim MY; Baik SK
    J Hepatol; 2019 Mar; 70(3):412-422. PubMed ID: 30389550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients.
    Marasco G; Dajti E; Ravaioli F; Alemanni LV; Capuano F; Gjini K; Colecchia L; Puppini G; Cusumano C; Renzulli M; Golfieri R; Festi D; Colecchia A
    Hepatol Int; 2020 Sep; 14(5):850-857. PubMed ID: 32557193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-MTHF enhances the portal pressure reduction achieved with propranolol in patients with cirrhosis: A randomized placebo-controlled trial.
    Vukotic R; Di Donato R; Roncarati G; Simoni P; Renzulli M; Gitto S; Schepis F; Villa E; Berzigotti A; Bosch J; Andreone P
    J Hepatol; 2023 Oct; 79(4):977-988. PubMed ID: 37482222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and 7-day portal pressure response to carvedilol and propranolol in cirrhotics.
    De BK; Das D; Sen S; Biswas PK; Mandal SK; Majumdar D; Maity AK
    J Gastroenterol Hepatol; 2002 Feb; 17(2):183-9. PubMed ID: 11966949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shear-wave elastography: a noninvasive tool for monitoring changing hepatic venous pressure gradients in patients with cirrhosis.
    Choi SY; Jeong WK; Kim Y; Kim J; Kim TY; Sohn JH
    Radiology; 2014 Dec; 273(3):917-26. PubMed ID: 25025464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using MR elastography to assess portal hypertension and response to beta-blockers in patients with cirrhosis.
    Danielsen KV; Hove JD; Nabilou P; Yin M; Chen J; Zhao M; Kallemose T; Teisner AS; Siebner HR; Ehman RL; Møller S; Bendtsen F
    Liver Int; 2021 Sep; 41(9):2149-2158. PubMed ID: 34060714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of beta-blockers on multiple haemodynamics in cirrhosis: A cross-over study by MR-imaging and hepatic vein catheterization.
    Danielsen KV; Nabilou P; Wiese SS; Hove JD; Bendtsen F; Møller S
    Liver Int; 2023 Oct; 43(10):2245-2255. PubMed ID: 37387503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension.
    Villanueva C; Albillos A; Genescà J; Abraldes JG; Calleja JL; Aracil C; Bañares R; Morillas R; Poca M; Peñas B; Augustin S; Garcia-Pagan JC; Pavel O; Bosch J
    Hepatology; 2016 Jan; 63(1):197-206. PubMed ID: 26422126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carvedilol versus propranolol effect on hepatic venous pressure gradient at 1 month in patients with index variceal bleed: RCT.
    Gupta V; Rawat R; Shalimar ; Saraya A
    Hepatol Int; 2017 Mar; 11(2):181-187. PubMed ID: 27624505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic Effects of Adding Simvastatin to Carvedilol for Primary Prophylaxis of Variceal Bleeding: A Randomized Controlled Trial.
    Vijayaraghavan R; Jindal A; Arora V; Choudhary A; Kumar G; Sarin SK
    Am J Gastroenterol; 2020 May; 115(5):729-737. PubMed ID: 32079861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study.
    Robic MA; Procopet B; Métivier S; Péron JM; Selves J; Vinel JP; Bureau C
    J Hepatol; 2011 Nov; 55(5):1017-24. PubMed ID: 21354450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carvedilol or propranolol in portal hypertension? A randomized comparison.
    Hobolth L; Møller S; Grønbæk H; Roelsgaard K; Bendtsen F; Feldager Hansen E
    Scand J Gastroenterol; 2012 Apr; 47(4):467-74. PubMed ID: 22401315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal hypertension is the main driver of liver stiffness in advanced liver cirrhosis.
    Lunova M; Frankova S; Gottfriedova H; Senkerikova R; Neroldova M; Kovac J; Kieslichova E; Lanska V; Sticova E; Spicak J; Jirsa M; Sperl J
    Physiol Res; 2021 Aug; 70(4):563-577. PubMed ID: 34062072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.